SAN ANTONIO--(BUSINESS WIRE)--#BIAF--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for ...
News
- bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024 - BioSpace
- Biotech firm could anchor $95M Cortex development - St. Louis Business Journal
San Antonio · San Francisco · Seattle · Silicon ... Biotech firm could anchor $95M Cortex development ... Fiorello did not name the prospective anchor ...
- Medicenna Announces Upcoming Presentations at the 29th Annual Meeting of the Society ...
... San Antonio Breast Cancer Symposium (SABCS), the world's largest breast ... Q3 Biotech Earnings Recap: Nkarta, Intellia, Cassava and more.
- MPM BioImpact Appoints Michael Ehlers, M.D., Ph.D., Experienced R&D Leader and ...
He will also remain on the Board of Directors of ATP portfolio companies Aulos Bioscience and Replicate Bioscience. ... San Antonio, TX. October 03, ...
- FDA launched safety review into broken IUDs after Spotlight inquiry, but questions remain
... biomedical literature, epidemiological studies, product quality reports and other sources. 5.Documents reveal that CooperSurgical has asserted it ...